A1M (alpha-1-microglobulin) is a natural, endogenous protein which has many functions in the body. It may be described as:
- a protector against free hemoglobin
- an antioxidant
- a radical inhibitor
- a tissue repair agent
A1M has great therapeutic potential
A1M is a candidate for many therapeutic and diagnostic uses. Preclinical studies implies that A1M can prevent and ameliorate some of the damage caused by oxidative stress and inflammation.
Under development: therapies for pre-eclampsia and kidney damage
Two research groups at Lund University, led by Bo Åkerström and Stefan Hansson, focus on two therapeutic areas:
A medication for intravenous treatment is under development. Clinical studies have been performed on animal models.
• Kidney damage
Studies are currently being performed to learn more about A1M’s therapeutic effects in different types of kidney damage and disorders.